Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis
暂无分享,去创建一个
S. Messé | M. Crowther | Jiayi Tong | C. Chai-Adisaksopha | D. Garcia | A. Cuker | T. Chiasakul | Yong Chen | Elizabeth De Jesus
[1] Natural anticoagulant deficiencies in Thais: A population-based study. , 2019, Thrombosis research.
[2] H. Kamel,et al. Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[3] C. Leissinger,et al. A cross-sectional analysis of cardiovascular disease in the hemophilia population. , 2018, Blood advances.
[4] B. Kissela,et al. Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS) , 2018, Thrombosis and Haemostasis.
[5] S. Connolly,et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.
[6] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[7] D. Nagaraja,et al. A genetic study of Factor V Leiden (G1691A) mutation in young ischemic strokes with large vessel disease in a South Indian population , 2017, Journal of Clinical Neuroscience.
[8] Stacy A. Johnson,et al. Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center , 2017, Journal of hospital medicine.
[9] Deepak L. Bhatt,et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.
[10] Kibum Kim,et al. Stroke diagnosis associated with thrombophilia testing overutilization. , 2017, Thrombosis research.
[11] S. Misra,et al. Relationship between Factor V Leiden Gene Variant and Risk of Ischemic Stroke: A Case–Control Study , 2017, Annals of Indian Academy of Neurology.
[12] M. Atadzhanov,et al. HIV infection, hypercoagulability and ischaemic stroke in adults at the University Teaching Hospital in Zambia: a case control study , 2017, BMC Infectious Diseases.
[13] S. Goldhaber,et al. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) , 2017, Circulation.
[14] C. Schooling,et al. Plasma levels of the anti-coagulation protein C and the risk of ischaemic heart disease , 2016, Thrombosis and Haemostasis.
[15] T. Miyata,et al. Thrombophilia in East Asian countries: are there any genetic differences in these countries? , 2016, Thrombosis Journal.
[16] M. Spiroski,et al. Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia , 2016, Open access Macedonian journal of medical sciences.
[17] J. Lee,et al. Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.
[18] A. Hvas,et al. Thrombophilia testing in young patients with ischemic stroke. , 2016, Thrombosis research.
[19] N. Erten,et al. Prevalence Of Thrombophilic Mutations In Ischemic Stroke Patients In Isparta, Turkey , 2015 .
[20] J. Filipovský,et al. Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. , 2015, Atherosclerosis.
[21] A. Tavernarakis,et al. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[22] J. O’Connell,et al. Prothrombin G20210A Mutation Is Associated With Young-Onset Stroke: The Genetics of Early-Onset Stroke Study and Meta-Analysis , 2014, Stroke.
[23] V. V. Solter,et al. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[24] M. Behari,et al. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out? , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[25] J. O’Connell,et al. Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[26] Comparative analysis of associations between polymorphic variants of the F2, F5, GP1BA, and ACE genes and the risk of developing stroke in Russian and Ukrainian populations , 2013, Molecular Genetics, Microbiology and Virology.
[27] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[28] M. Sartori,et al. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale. , 2012, Thrombosis research.
[29] D. Radojkovic,et al. Prothrombotic Genetic Risk Factors in Stroke , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[30] M. Endres,et al. Thrombophilia screening in young patients with cryptogenic stroke , 2012, Hämostaseologie.
[31] P. Angchaisuksiri. Venous thromboembolism in Asia – an unrecognised and under-treated problem? , 2011, Thrombosis and Haemostasis.
[32] F. Leebeek,et al. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review , 2011, Journal of thrombosis and haemostasis : JTH.
[33] Prothrombin G20210A and Factor V Leiden Polymorphisms in Stroke , 2011, Journal of Molecular Neuroscience.
[34] M. Fisher,et al. Testing for Inherited Thrombophilias in Arterial Stroke: Can It Cause More Harm Than Good? , 2010, Stroke.
[35] S. Kittner,et al. Meta-Analysis of Factor V Leiden and Ischemic Stroke in Young Adults: The Importance of Case Ascertainment , 2010, Stroke.
[36] S. Kravchenko,et al. Ischemic stroke in Ukrainian population: possible involvement of the F2 G20210A, F5 G1691A and MTHFR C677T gene variants , 2010 .
[37] T. Klockgether,et al. Common genetic coagulation variants are not associated with ischemic stroke in a case-control study , 2010, Neurological research.
[38] F. Kirkham,et al. Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies , 2010, Circulation.
[39] A. Folsom,et al. Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study , 2010, Cerebrovascular Diseases.
[40] A. Mokdad,et al. Gene polymorphisms in association with self-reported stroke in US adults , 2010, The application of clinical genetics.
[41] E. Stępień,et al. Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale , 2009, Thrombosis and Haemostasis.
[42] M. Behari,et al. Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. , 2009, Thrombosis research.
[43] N. D. de Bosch,et al. Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case-control study in Venezuela. , 2009, Genetic testing and molecular biomarkers.
[44] A. C. Yazici,et al. Prevalence of Thrombophilic Mutations and ACE I/D Polymorphism in Turkish Ischemic Stroke Patients , 2009, Clinical and applied thrombosis/hemostasis.
[45] D. Moher,et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.
[46] H. ten Cate,et al. Is thrombin a key player in the 'coagulation-atherogenesis' maze? , 2009, Cardiovascular research.
[47] A. Grau,et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? , 2009, Thrombosis and Haemostasis.
[48] N. Kıylıoğlu,et al. Hereditary Thrombophilic Factors in Stroke Due to Cerebral Infarct , 2009, The American journal of the medical sciences.
[49] Yajie Wang,et al. The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[50] M. Schindewolf,et al. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? , 2008, Thrombosis research.
[51] D. Tanné,et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.
[52] Lina Badimon,et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis , 2008, Thrombosis and Haemostasis.
[53] Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[54] L. Iacoviello,et al. Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[55] J. Martí-Fàbregas,et al. Diagnostic yield of prothrombotic state studies in cryptogenic stroke , 2006, Acta neurologica Scandinavica.
[56] C. McCollum,et al. Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). , 2006, Journal of the American College of Cardiology.
[57] M. Prins,et al. A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation. , 2006, Blood.
[58] P. Mannucci,et al. Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke. , 2006, Haematologica.
[59] G. Assenza,et al. A role of TNF‐α gene variant on juvenile ischemic stroke: a case–control study , 2005 .
[60] G. Modi,et al. Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[61] T. Ulutin,et al. Factor V Leiden Mutation in Cerebrovascular Disease , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[62] A. Algra,et al. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke , 2005, Journal of thrombosis and haemostasis : JTH.
[63] B. Gigante,et al. Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population , 2005, Thrombosis and Haemostasis.
[64] A. Padovani,et al. Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults , 2005, Stroke.
[65] J. Rovenský,et al. Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[66] D. Corella,et al. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke , 2004, Thrombosis and Haemostasis.
[67] D. Singer,et al. Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2003, Journal of Thrombosis and Thrombolysis.
[68] R. Becker,et al. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. , 2003, American heart journal.
[69] A. Kondacs,et al. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke , 2003, Journal of neurology, neurosurgery, and psychiatry.
[70] C. Wolfe,et al. Ethnic Differences in Markers of Thrombophilia: Implications for the Investigation of Ischemic Stroke in Multiethnic Populations: The South London Ethnicity and Stroke Study , 2003, Stroke.
[71] B. Peterlin,et al. Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction , 2003, Acta neurologica Scandinavica.
[72] M. Hillbom,et al. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[73] Yung-Yee Chang,et al. The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia , 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[74] B. Nordestgaard,et al. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.
[75] A. Arnold,et al. No Association of Plasma Prothrombin Concentration or the G20210A Mutation with Incident Cardiovascular Disease , 2002, Thrombosis and Haemostasis.
[76] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.
[77] H. Kwiecinski,et al. Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[78] M. Prins,et al. A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous Thromboembolism , 2001, Annals of Internal Medicine.
[79] G. Hankey,et al. Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes , 2001, Stroke.
[80] J Q Shi,et al. A sensitivity analysis for publication bias in systematic reviews , 2001, Statistical methods in medical research.
[81] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[82] B. Damasceno,et al. Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults , 2000, Thrombosis and Haemostasis.
[83] P. Ridker,et al. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. , 1999, Circulation.
[84] D. De Lucia,et al. Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke. , 1999, Journal of neurosurgical sciences.
[85] N. Erba,et al. Genetic Abnormalities of the Protein C System: Shared Risk Factors in Young Adults with Migraine with Aura and with Ischemic Stroke? , 1998, Cephalalgia : an international journal of headache.
[86] H. Lutsep,et al. Lack of prothrombin gene mutation in young stroke patients , 1998 .
[87] L. Kuller,et al. Factor V Leiden Is not a Risk Factor for Arterial Vascular Disease in the Elderly: Results from the Cardiovascular Health Study , 1998, Thrombosis and Haemostasis.
[88] T. Raghunathan,et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) , 1998, Stroke.
[89] L. Iacoviello,et al. A hypercoagulable state in activated protein C resistant patients with ischemic stroke , 1998, International journal of clinical & laboratory research (Print).
[90] M. Fischer,et al. The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot study. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[91] F. Woimant,et al. Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young. , 1997, Stroke.
[92] F. Woimant,et al. Different contribution of factor V Leiden-associated hypercoagulability to ischaemic cerebrovascular disease in the elderly. , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[93] Y. Shinohara,et al. Low Prevalence of Activated Protein C Resistance and Factor V Leiden in Ischemic Stroke in Japan , 1996 .
[94] R. Press,et al. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. , 1996, Stroke.
[95] J. Barrett,et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[96] P. Ridker,et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.
[97] W. Halbmayer,et al. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[98] S. Mayer,et al. Free Protein S Deficiency in Acute Ischemic Stroke: A Case‐Control Study , 1993, Stroke.